One man’s “liquidity event” is another investor’s false alarm.
The Bezos pattern: pre-announcement systematic sells under 10b5-1 plans
Jeff Bezos has sold so much Amazon stock over the years that the raw dollar totals can make even seasoned investors briefly forget how securities law works.
That is the point of this profile. Not to romanticise founder selling, and not to wave it away either, but to separate signal from theatre. Bezos is one of the cleanest examples of a founder using Rule 10b5-1 plans as intended, or at least as sophisticated issuers and their counsel have long preferred to use them, to turn a potentially messy stream of insider sales into a pre-committed, legally defensible programme. Investors who read insider filings casually often see only the final act, the Form 4, the headline, the cash figure, the “why is he selling now?” question. The more useful analysis starts earlier, with the plan.
The central lesson is almost boring, which is why it matters. A founder who sells through a systematic 10b5-1 plan is often telling you less about short-term valuation than a founder who suddenly appears in the market without one. Boring, in markets, is underrated.
What investors think they see when Bezos sells
The usual interpretation of a founder sale is straightforward enough. If the person who knows the business best is selling, perhaps they think the stock is fully valued, or worse. That logic is not absurd. It is also frequently lazy.
With Bezos, the first thing to note is that the market has had years of practice processing his sales. He has sold stock to fund Blue Origin, philanthropy, and personal diversification. He has also remained, despite those sales, one of Amazon’s largest shareholders. That combination matters. A founder reducing exposure from an enormous concentrated stake is not the same as a marginal insider heading for the exit.
The headline problem
Large founder sales are irresistible headlines because the nominal dollar values are enormous. A disposal of a few million shares in Amazon can translate into sums that sound like a sovereign wealth fund’s lunch break. The numbers are real. The interpretation is where things go off the rails.
A Form 4 tells you that a transaction happened and when it was executed. It may also indicate that the trade was made pursuant to a Rule 10b5-1 plan. What it does not do, at least not by itself, is prove that the insider made a fresh discretionary decision at the moment of sale. In a plan-based sale, the meaningful decision may have been made months earlier, under different information conditions and legal constraints.
This is why investors who react to the filing date rather than the plan architecture are often trading on stale psychology.
Why Bezos is a useful case study
Bezos is not useful because he is average. He plainly is not. He is useful because the pattern is visible. Repeated use of 10b5-1 plans creates a record of how a founder can monetise stock while reducing accusations of opportunism. It also shows investors what to inspect:
- Was the sale made under a disclosed 10b5-1 plan?
- When was the plan adopted relative to the trade date?
- Is the selling cadence regular or opportunistic?
- How large is the sale relative to the founder’s remaining stake?
- Are there overlapping plans or signs of plan modification?
- Does the sale occur near earnings, guidance changes, major contracts, or strategic announcements?
With Bezos, much of the answer to item three has historically been “regular enough to be unexciting”, which is not a phrase designed to trend on finance social media.
The legal machinery: what 10b5-1 is supposed to do
Rule 10b5-1 was designed to solve a practical problem. Corporate insiders often hold large amounts of stock and need to sell for ordinary reasons, but they are almost always at risk of being accused of trading while aware of material nonpublic information. The rule offers an affirmative defence if trades occur under a binding contract, instruction, or written plan adopted when the insider was not aware of material nonpublic information, and if the plan specifies the amount, price, and date, or includes a formula or algorithm that determines them.
That sounds neat in theory. In practice, the history of 10b5-1 is a long argument over whether it became too neat.
The original bargain
The original regulatory bargain was simple. If an insider commits in advance to a trading programme and then stays out of the way, the eventual trades should not be treated as suspicious simply because the insider later comes into possession of inside information before execution. The plan acts as a sort of legal time capsule.
For founders, this is attractive for obvious reasons. They can diversify without trying to guess blackout windows, investor sentiment, or whether every sale will be interpreted as a coded message. For boards and counsel, it reduces litigation and optics risk. For the market, at least in theory, it improves predictability.
The loophole problem
The criticism, well documented over the years by academics, journalists, and regulators, is that some insiders used 10b5-1 plans too flexibly. If a plan can be adopted, modified, cancelled, or overlapped with another plan too easily, then the supposed pre-commitment starts to look less like a restraint and more like a costume.
That criticism eventually led to the SEC’s 2022 amendments. Those changes imposed cooling-off periods for directors and officers, restricted overlapping plans, limited single-trade plans, and added disclosure requirements for issuers. The SEC’s message was not subtle: if you want the protection of a pre-arranged plan, it should actually be pre-arranged.
Why modern investors should care about the rule change
This matters for any “Bezos pattern” analysis because older founder-selling case studies often span years when the rule was looser in practice. Investors should be careful not to map every historical pattern directly onto the post-2022 regime.
A modern 10b5-1 plan for an officer or director now generally requires a cooling-off period of the later of 90 days after adoption or modification, or two business days after disclosure of the issuer’s financial results for the quarter in which the plan was adopted, subject to a cap of 120 days. There are also certifications for directors and officers, plus restrictions on overlapping plans and repeated single-trade plans.
In short, the legal plumbing has become less permissive. Good. It was due for maintenance.
How Bezos structures the sales, at least from the outside
Outside investors do not get the full plan document. They get filings, disclosures, timing, and patterns. That is enough to infer a fair amount, if not enough to satisfy the nosier corners of the internet.
Planned, not impulsive
The defining feature of Bezos’s stock disposals has been their systematic nature. Press coverage and SEC filings have repeatedly indicated that sales were made pursuant to Rule 10b5-1 trading plans. That means the execution dates and quantities were generally set in advance, or determined by formula, before the trades occurred.
This distinction is not cosmetic. A founder who wakes up, sees a strong quarter, and decides to dump stock that afternoon is making an active valuation call. A founder whose broker executes a scheduled sale under a standing plan may simply be following a calendar.
There is still room for judgement, of course. The real discretion may lie in when the plan is adopted, how much stock it covers, and whether the founder chooses to renew or suspend future plans. But that is a slower, more structural form of signalling.
Cadence matters more than any single sale
Investors tend to overweight one filing and underweight the sequence. With Bezos, the better question is whether sales appear in a recurring cadence that looks detached from immediate news flow. If so, the market should discount the informational content of each individual disposal.
A useful framework is to classify founder sales into three buckets:
| Bucket | Description | Likely informational value |
|---|---|---|
| Systematic plan sales | Repeated sales under a disclosed 10b5-1 plan, with regular cadence | Low to moderate |
| Semi-systematic sales | Plan-based, but irregular in size or clustered around notable events | Moderate |
| Discretionary sales | No clear plan disclosure, sudden timing, unusual size | Moderate to high |
Bezos typically sits in the first bucket more often than the third. That does not make the trades meaningless. It makes them different.
Size relative to ownership
A founder can sell billions and still not be “leaving”. This is one of the more annoying arithmetic facts in mega-cap founder analysis. Because Bezos’s stake has historically been so large, even substantial sales often represented only a modest fraction of his total holdings.
That is why post-transaction ownership matters. If a founder sells 2 percent of a position and retains overwhelming exposure, the sale is more plausibly interpreted as liquidity management. If the founder sells 30 percent in a compressed period, the conversation changes.
The SEC filing regime gives investors enough information to do this math. Most people simply prefer not to, because “sold $n/a billion” is easier to tweet than “reduced stake by a low-single-digit percentage while retaining alignment”.
What investors can actually learn from the pattern
The practical value of studying Bezos is not to predict his next sale. It is to improve your filter for founder transactions generally.
Lesson one: separate execution from intent
The execution date is often the least interesting date in a 10b5-1 trade. The intent date, meaning the plan adoption date, is more important. Under the updated SEC rules, that date now carries even more analytical weight because cooling-off periods make last-minute opportunism harder.
If an investor sees a founder sale just after a major announcement, the immediate temptation is to infer that the founder is cashing out on good news. Under a valid 10b5-1 plan, that may be exactly the wrong inference. The sale may have been set in motion long before the announcement.
This does not eliminate all concern. Founders may still choose when to adopt plans, and that timing itself can be informative. But it shifts the analysis from “why sell today?” to “why put this plan in place when they did?”
Lesson two: look for departures from the founder’s own norm
The most informative insider trades are often not large in absolute terms. They are unusual relative to the insider’s history.
For Bezos, investors should ask whether the sale pattern departs from prior cadence. Has the volume accelerated? Has the spacing changed? Is there a new concentration around windows that had previously been avoided? Is there a pause after years of regular selling? Sometimes the absence of a known pattern is the signal.
This is where a profile approach beats a one-off filing read. You are not just evaluating a transaction. You are evaluating a behavioural series.
Lesson three: pair insider data with ownership context
Founder sales mean less when ownership remains large, voting influence remains intact, and incentives remain aligned. They mean more when they coincide with shrinking ownership, reduced operating involvement, or strategic drift.
Bezos stepped down as Amazon CEO in 2021 but remained executive chair. That governance shift matters. Investors should read founder sales differently when the founder’s role changes. A founder-CEO selling under a plan is one thing. A founder who is increasingly removed from day-to-day operations but still monetising stock is another. Neither is inherently bearish. Both require context.
Lesson four: use sales asymmetrically
Academic literature on insider trading has long found that insider purchases tend to be more informative than insider sales. Purchases are usually voluntary and concentrated. Sales have many motives. This asymmetry is especially important for founders with concentrated wealth.
So the right investor stance is not “ignore founder sales”. It is “demand more corroboration before treating founder sales as a negative signal”. A systematic 10b5-1 sale by Bezos, standing alone, should usually clear a fairly high threshold before it changes your thesis on Amazon.
The post-2022 reality: 10b5-1 is less forgiving now
A great deal of popular commentary on 10b5-1 still sounds as if the rule has not changed. It has.
Cooling-off periods changed the optics
The SEC’s 2022 amendments made it harder for directors and officers to adopt a plan and then trade quickly. That cooling-off period is not merely a technical footnote. It changes how investors should read the timing of sales around earnings and major news.
If a founder sale occurs under a recently adopted plan, there should now be a meaningful lag before execution for covered insiders. That weakens the old critique that insiders could opportunistically set up plans shortly before favourable disclosures and then claim safe harbour.
It does not eliminate gaming entirely. Few legal regimes manage that trick. But it raises the cost of abuse and improves the credibility of genuinely systematic plans.
Overlapping plans are now riskier
One historical criticism was that insiders could maintain multiple plans, then selectively cancel or rely on whichever one turned out best. The SEC has narrowed that flexibility. Restrictions on overlapping plans and repeated single-trade plans are intended to preserve the core logic of pre-commitment.
For investors, this means a disclosed 10b5-1 plan in the current regime deserves somewhat more respect than one did in the more elastic era. Not blind respect, certainly. But more.
Company disclosure is improving, slowly
The 2022 amendments also require issuers to provide periodic disclosure about insider trading policies and the adoption or termination of Rule 10b5-1 arrangements by directors and officers. This should gradually make plan analysis easier, though “gradually” is doing some heavy lifting.
Investors still need to read footnotes, annual reports, proxy materials, and periodic filings with care. The information is there more often than it used to be. It is just not arranged for your convenience, which remains one of the SEC filing system’s more durable traditions.
A comparison point: why the US framework stands out
Bezos is a US case, and 10b5-1 is a peculiarly American answer to a universal problem. Other markets regulate insider dealing and disclosure, but the mechanics differ.
| Market | Regulator | Rule | Deadline | Notes |
|---|---|---|---|---|
| US | SEC | Rule 10b5-1 and Section 16 | Form 4 within 2 business days | Affirmative defense for pre-arranged plans, with 2022 cooling-off and disclosure amendments. |
| FR | AMF | MAR Art 19 | T+3 business days | Managers' transactions must be notified promptly under EU Market Abuse Regulation; no direct equivalent to US 10b5-1 affirmative defense structure. |
| EU | ESMA and national regulators | MAR Art 19 | T+3 business days | Closed periods and PDMR disclosure framework dominate analysis, rather than a US-style plan safe harbour. |
Why this matters for investors reading global founder sales
If you analyse founder transactions across markets, do not assume every scheduled-looking sale has a 10b5-1 analogue behind it. Under the EU Market Abuse Regulation, persons discharging managerial responsibilities, PDMRs, must disclose transactions within three business days, and issuers must make them public. But the legal framing is different. Closed periods and disclosure obligations carry more of the analytical burden.
The US system, by contrast, gives investors a specific concept, the 10b5-1 plan, around which to organise interpretation. That can be useful, but it can also encourage a false sense of certainty. A plan is not a moral certificate. It is a legal structure with varying degrees of integrity depending on how it is used.
So, is the Bezos pattern bullish, bearish, or neither?
Annoyingly for anyone seeking a crisp market call, it is usually neither.
What it is not
It is not strong evidence, by itself, that Bezos thinks Amazon shares are overvalued at the moment of each sale. The use of pre-arranged plans weakens that inference substantially.
It is not evidence that founder alignment has vanished. A founder can sell large amounts and still remain heavily exposed.
It is also not a reason to ignore all selling. Persistent monetisation over years can still matter for governance, optics, and long-run ownership concentration.
What it is
It is evidence of disciplined liquidity management by a founder with an unusually concentrated equity position and unusually large external capital needs. Blue Origin is not financed with supermarket coupons. Neither is large-scale philanthropy.
It is also evidence that investors should study the architecture of insider trading plans, not merely the transaction tape. The plan is where intent becomes legible, at least partially.
The right investor response
For Amazon specifically, a Bezos sale under a disclosed 10b5-1 framework should usually be treated as low-grade information unless accompanied by something else, a role change, an acceleration in pace, a sharp reduction in retained ownership, or a broader pattern of insider weakness across the leadership team.
For founder-led companies more broadly, the Bezos template suggests a practical hierarchy:
- Discount routine plan sales.
- Focus on deviations from routine.
- Measure sales against remaining ownership.
- Check whether governance or operating roles are changing.
- Treat unplanned or poorly explained sales with more suspicion.
That hierarchy will not make headlines. It may, however, save investors from reacting theatrically to what is essentially a scheduled administrative event with many zeroes attached.
The open question is not whether Bezos will keep selling under plans. Founders with concentrated wealth generally do. The more useful next step is to build a cleaner investor dashboard for plan adoption dates, cooling-off periods, and post-sale ownership, because until that becomes standard, too much of the market will keep confusing choreography for confession.
Sources & further reading
- SEC final rule adopting Rule 10b5-1 under the Exchange Actregulator2000-08-15
- SEC final rule on insider trading arrangements and related disclosuresregulator2022-12-14
- SEC Investor Bulletin: Insider Transactions and Forms 3, 4 and 5regulator2023-02-24
- SEC Form 4 overviewregulator
- ESMA, Market Abuse Regulation (MAR)regulator
- AMF, Managers' dealingsregulator
- Jagolinzer, A. D., SEC Rule 10b5-1 and insiders' strategic tradepaper2009-01-01
- Henderson, M. T., Narayanan, Y., and others on 10b5-1 plan abuse and reform debatespaper
Editorial note, this article was assembled without live web research (Grok unavailable in this generation pass). Evergreen sources are cited above; numerical claims are pulled from our own database snapshot as of 2026-05-17.
Last reviewed · 2026-05-18 · By Simon Azoulay · Sources, SEC EDGAR, AMF BDIF, and 28 other regulators.
